# 21 CFR Part 111

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/21-cfr-part-111
Canonical HTML page: https://getbiobrief.com/entity/21-cfr-part-111

## Recent coverage (1 stories)

### Zeon's FDA FSMA + NSF 21 CFR Part 111 cGMP Boost India CDMO Credibility
2026-08-23 12:43:19 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

For biopharma and nutraceutical manufacturing leaders, Zeon Lifesciences' US FDA FSMA clearance and NSF 21 CFR Part 111 cGMP certification validate a quality system at the food/dietary supplement interface. The milestone positions the Indian CDMO to capture contract manufacturing demand from US dietary supplement and wellness brands that increasingly require pharma-like quality assurance. It underscores the convergence of cGMP rigor and FDA regulatory compliance outside traditional drug approvals.
Full story: https://getbiobrief.com/story/zeon-fda-fsma-nsf-cgmp-india-nutraceutical-cdmo

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.